Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis

医学 脂肪肝 荟萃分析 人口 疾病 肥胖 内科学 入射(几何) 科克伦图书馆 环境卫生 光学 物理
作者
Qing Ye,Biyao Zou,Yee Hui Yeo,Jie Li,Daniel Q. Huang,Yuankai Wu,Hongli Yang,Chuanli Liu,Leslie Y. Kam,Xiang Xuan Eunice Tan,Nicholas Chien,Sam Trinh,Linda Henry,Christopher D Stave,Tetsuya Hosaka,Ramsey Cheung,Mindie H. Nguyen
出处
期刊:The Lancet Gastroenterology & Hepatology [Elsevier]
卷期号:5 (8): 739-752 被引量:622
标识
DOI:10.1016/s2468-1253(20)30077-7
摘要

Although non-alcoholic fatty liver disease (NAFLD) is commonly associated with obesity, it is increasingly being identified in non-obese individuals. We aimed to characterise the prevalence, incidence, and long-term outcomes of non-obese or lean NAFLD at a global level.For this systematic review and meta-analysis, we searched PubMed, Embase, Scopus, and the Cochrane Library from inception to May 1, 2019, for relevant original research articles without any language restrictions. The literature search and data extraction were done independently by two investigators. Primary outcomes were the prevalence of non-obese or lean people within the NAFLD group and the prevalence of non-obese or lean NAFLD in the general, non-obese, and lean populations; the incidence of NAFLD among non-obese and lean populations; and long-term outcomes of non-obese people with NAFLD. We also aimed to characterise the demographic, clinical, and histological characteristics of individuals with non-obese NAFLD.We identified 93 studies (n=10 576 383) from 24 countries or areas: 84 studies (n=10 530 308) were used for the prevalence analysis, five (n=9121) were used for the incidence analysis, and eight (n=36 954) were used for the outcomes analysis. Within the NAFLD population, 19·2% (95% CI 15·9-23·0) of people were lean and 40·8% (36·6-45·1) were non-obese. The prevalence of non-obese NAFLD in the general population varied from 25% or lower in some countries (eg, Malaysia and Pakistan) to higher than 50% in others (eg, Austria, Mexico, and Sweden). In the general population (comprising individuals with and without NAFLD), 12·1% (95% CI 9·3-15·6) of people had non-obese NAFLD and 5·1% (3·7-7·0) had lean NAFLD. The incidence of NAFLD in the non-obese population (without NAFLD at baseline) was 24·6 (95% CI 13·4-39·2) per 1000 person-years. Among people with non-obese or lean NALFD, 39·0% (95% CI 24·1-56·3) had non-alcoholic steatohepatitis, 29·2% (21·9-37·9) had significant fibrosis (stage ≥2), and 3·2% (1·5-5·7) had cirrhosis. Among the non-obese or lean NAFLD population, the incidence of all-cause mortality was 12·1 (95% CI 0·5-38·8) per 1000 person-years, that for liver-related mortality was 4·1 (1·9-7·1) per 1000 person-years, cardiovascular-related mortality was 4·0 (0·1-14·9) per 1000 person-years, new-onset diabetes was 12·6 (8·0-18·3) per 1000 person-years, new-onset cardiovascular disease was 18·7 (9·2-31·2) per 1000 person-years, and new-onset hypertension was 56·1 (38·5-77·0) per 1000 person-years. Most analyses were characterised by high heterogeneity.Overall, around 40% of the global NAFLD population was classified as non-obese and almost a fifth was lean. Both non-obese and lean groups had substantial long-term liver and non-liver comorbidities. These findings suggest that obesity should not be the sole criterion for NAFLD screening. Moreover, clinical trials of treatments for NAFLD should include participants across all body-mass index ranges.None.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
过儿完成签到,获得积分10
2秒前
fafa完成签到 ,获得积分10
4秒前
dtoakm发布了新的文献求助10
4秒前
毅诚菌完成签到,获得积分10
4秒前
过儿发布了新的文献求助10
7秒前
CodeCraft应助dtoakm采纳,获得10
8秒前
琉璃苣应助乐观的谷波采纳,获得10
14秒前
dtoakm完成签到,获得积分10
15秒前
同學你該吃藥了完成签到 ,获得积分10
15秒前
18秒前
leek完成签到 ,获得积分10
18秒前
科研通AI2S应助过儿采纳,获得10
19秒前
CodeCraft应助奇奇吃面采纳,获得10
19秒前
lily88发布了新的文献求助10
21秒前
22秒前
23秒前
阿咚完成签到,获得积分10
23秒前
无花果应助竹外桃花采纳,获得200
24秒前
开心超人发布了新的文献求助10
26秒前
海边听海完成签到 ,获得积分10
27秒前
ZYH完成签到,获得积分10
27秒前
31秒前
Chem完成签到,获得积分10
32秒前
Owen应助开心超人采纳,获得10
35秒前
Bazinga完成签到,获得积分10
35秒前
Myx完成签到,获得积分10
36秒前
你好啊发布了新的文献求助10
37秒前
就在海里完成签到,获得积分10
39秒前
搜集达人应助你好啊采纳,获得10
44秒前
45秒前
45秒前
龙虾发票完成签到,获得积分10
46秒前
Vet梁完成签到,获得积分10
46秒前
48秒前
hesongwen发布了新的文献求助10
49秒前
Darren发布了新的文献求助10
49秒前
以甲引丁发布了新的文献求助30
49秒前
科研通AI2S应助Chem采纳,获得10
52秒前
lulalula完成签到,获得积分10
54秒前
高分求助中
Sustainability in Tides Chemistry 2800
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Handbook of Qualitative Cross-Cultural Research Methods 600
Very-high-order BVD Schemes Using β-variable THINC Method 568
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3137627
求助须知:如何正确求助?哪些是违规求助? 2788531
关于积分的说明 7787471
捐赠科研通 2444861
什么是DOI,文献DOI怎么找? 1300119
科研通“疑难数据库(出版商)”最低求助积分说明 625814
版权声明 601023